D. Chahodiya
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: University of Wisconsin–Madison (2026); New York Hospital Queens (2026); Presbyterian Hospital (2026); Government Medical College (2025–2026)
Faculty Researcher
Research Areas
Biography and Research Information
OverviewAI-generated summary
D. Chahodiya's research focuses on analyzing large datasets to identify trends and disparities in health outcomes, particularly within the context of cancer and chronic diseases. Recent work includes an examination of procedure-related mortality among older U.S. adults with digestive system malignancies, utilizing the CDC WONDER database over a 24-year period. Other investigations explore demographic and regional trends in mortality related to combined colorectal cancer and cerebrovascular disease. Chahodiya also conducts systematic reviews and meta-analyses of randomized controlled trials to evaluate therapeutic efficacies. These include studies on the addition of panitumumab to chemotherapy regimens for metastatic colorectal cancer, the effectiveness of different therapies for *Helicobacter pylori* eradication, and the impact of dapagliflozin on liver fibrosis and metabolic parameters in patients with metabolic dysfunction-associated steatotic liver disease. Collaborations include extensive work with L. Thaker, with 19 shared publications.
Metrics
- h-index: 1
- Publications: 25
- Citations: 2
Selected Publications
-
E-93 | Population-level Impact of Advancing Valvular Interventions on Mortality from Atrial Fibrillation and Flutter Among Adults with Nonrheumatic Valvular Heart Disease in the United States: A CDC-WONDER Analysis from 1999-2023 (2026)
Collaboration Network
Top Collaborators
- E-93 | Population-level Impact of Advancing Valvular Interventions on Mortality from Atrial Fibrillation and Flutter Among Adults with Nonrheumatic Valvular Heart Disease in the United States: A CDC-WONDER Analysis from 1999-2023
- E-93 | Population-level Impact of Advancing Valvular Interventions on Mortality from Atrial Fibrillation and Flutter Among Adults with Nonrheumatic Valvular Heart Disease in the United States: A CDC-WONDER Analysis from 1999-2023
- E-93 | Population-level Impact of Advancing Valvular Interventions on Mortality from Atrial Fibrillation and Flutter Among Adults with Nonrheumatic Valvular Heart Disease in the United States: A CDC-WONDER Analysis from 1999-2023
- E-93 | Population-level Impact of Advancing Valvular Interventions on Mortality from Atrial Fibrillation and Flutter Among Adults with Nonrheumatic Valvular Heart Disease in the United States: A CDC-WONDER Analysis from 1999-2023
- E-93 | Population-level Impact of Advancing Valvular Interventions on Mortality from Atrial Fibrillation and Flutter Among Adults with Nonrheumatic Valvular Heart Disease in the United States: A CDC-WONDER Analysis from 1999-2023
Similar Researchers
Based on overlapping research topics